Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | -8.33% | -8.33% | -21.43% |
05-15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-01 | Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-21.43% | 12.09M | |
+9.88% | 118B | |
+10.24% | 106B | |
-11.33% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.68% | 15.97B | |
+6.83% | 14.03B | |
+17.92% | 11.67B |
- Stock Market
- Equities
- RVX Stock
- News Resverlogix Corp.
- Resverlogix Expands Phase 2b Clinical Trial for COVID-19 Treatment with First Site in Brazil and Second in Canada